End-of-day quote
Trinidad and Tobago S.E.
06:00:00 2024-05-16 pm EDT
|
5-day change
|
1st Jan Change
|
57
TTD
|
0.00%
|
|
0.00%
|
+5.44%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
9,481
|
9,513
|
9,213
|
10,224
|
8,871
|
9,320
|
Enterprise Value (EV)
1 |
7,062
|
7,356
|
6,056
|
5,715
|
5,006
|
5,787
|
P/E ratio
|
15.6
x
|
14.8
x
|
21.7
x
|
17.2
x
|
44.9
x
|
18
x
|
Yield
|
3.27%
|
0.54%
|
3.08%
|
3.03%
|
3.5%
|
3.33%
|
Capitalization / Revenue
|
1.48
x
|
1.44
x
|
1.56
x
|
1.71
x
|
1.36
x
|
1.35
x
|
EV / Revenue
|
1.11
x
|
1.12
x
|
1.02
x
|
0.96
x
|
0.77
x
|
0.84
x
|
EV / EBITDA
|
6.56
x
|
6.98
x
|
6.33
x
|
6.72
x
|
6.12
x
|
6.63
x
|
EV / FCF
|
9.82
x
|
-36.7
x
|
10.7
x
|
5.3
x
|
30.1
x
|
8.2
x
|
FCF Yield
|
10.2%
|
-2.72%
|
9.31%
|
18.9%
|
3.32%
|
12.2%
|
Price to Book
|
1.3
x
|
1.24
x
|
1.15
x
|
1.24
x
|
1.11
x
|
1.13
x
|
Nbr of stocks (in thousands)
|
172,386
|
172,345
|
172,205
|
171,856
|
172,252
|
172,405
|
Reference price
2 |
55.00
|
55.20
|
53.50
|
59.49
|
51.50
|
54.06
|
Announcement Date
|
4/30/19
|
4/30/20
|
5/3/21
|
3/29/22
|
4/24/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,385
|
6,593
|
5,919
|
5,970
|
6,525
|
6,919
|
EBITDA
1 |
1,077
|
1,054
|
956.5
|
850.5
|
818.4
|
872.4
|
EBIT
1 |
758.3
|
713.4
|
602.9
|
491.7
|
452.8
|
467
|
Operating Margin
|
11.88%
|
10.82%
|
10.19%
|
8.24%
|
6.94%
|
6.75%
|
Earnings before Tax (EBT)
1 |
1,017
|
1,036
|
723.3
|
935.3
|
433.9
|
841.8
|
Net income
1 |
609.4
|
644.8
|
423.2
|
594.8
|
197.7
|
516.6
|
Net margin
|
9.54%
|
9.78%
|
7.15%
|
9.96%
|
3.03%
|
7.47%
|
EPS
2 |
3.536
|
3.740
|
2.460
|
3.450
|
1.147
|
2.996
|
Free Cash Flow
1 |
718.9
|
-200.4
|
563.9
|
1,079
|
166.1
|
706
|
FCF margin
|
11.26%
|
-3.04%
|
9.53%
|
18.07%
|
2.55%
|
10.2%
|
FCF Conversion (EBITDA)
|
66.74%
|
-
|
58.96%
|
126.82%
|
20.29%
|
80.92%
|
FCF Conversion (Net income)
|
117.97%
|
-
|
133.24%
|
181.33%
|
84.02%
|
136.65%
|
Dividend per Share
2 |
1.800
|
0.3000
|
1.650
|
1.800
|
1.800
|
1.800
|
Announcement Date
|
4/30/19
|
4/30/20
|
5/3/21
|
3/29/22
|
4/24/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,419
|
2,157
|
3,157
|
4,508
|
3,865
|
3,533
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
719
|
-200
|
564
|
1,079
|
166
|
706
|
ROE (net income / shareholders' equity)
|
9.03%
|
9.29%
|
5.74%
|
7.62%
|
2.73%
|
6.45%
|
ROA (Net income/ Total Assets)
|
3.2%
|
2.87%
|
2.39%
|
1.85%
|
1.61%
|
1.62%
|
Assets
1 |
19,054
|
22,456
|
17,676
|
32,094
|
12,261
|
31,856
|
Book Value Per Share
2 |
42.40
|
44.60
|
46.30
|
48.00
|
46.60
|
47.80
|
Cash Flow per Share
2 |
9.470
|
10.30
|
16.40
|
14.50
|
12.40
|
8.460
|
Capex
1 |
355
|
742
|
330
|
364
|
441
|
677
|
Capex / Sales
|
5.56%
|
11.25%
|
5.58%
|
6.09%
|
6.76%
|
9.78%
|
Announcement Date
|
4/30/19
|
4/30/20
|
5/3/21
|
3/29/22
|
4/24/23
|
4/29/24
|
|
1st Jan change
|
Capi.
|
---|
| +5.44% | 1.45B | | +5.41% | 105B | | -3.11% | 64.71B | | +73.33% | 49.72B | | +17.24% | 38.6B | | +6.13% | 32.54B | | +12.77% | 19.94B | | +15.03% | 16.92B | | +19.06% | 15.2B | | +6.28% | 14.39B |
Other Commodity Chemicals
|